Client News
Filter by:
- Nov 20 2020 Q BioMed's Strontium89 Advertisement "Unfinished Business" Selected for Prestigious Ads of the World's Best Creative Campaigns
- Nov 16 2020 Q BioMed's Uttroside-B Receives U.S. Patent in Treatment of Liver Cancer
- Nov 16 2020 Retrophin Announces Corporate Name Change to Travere Therapeutics, Inc.
- Nov 16 2020 Retrophin Announces Corporate Name Change to Travere Therapeutics, Inc.
- Nov 12 2020 VistaGen Therapeutics Reports Fiscal 2021 Second Quarter Financial Results and Provides Highlights on its CNS Pipeline and Business Progress
- Nov 12 2020 Retrophin Completes Acquisition of Orphan Technologies
- Nov 12 2020 VistaGen Reports Positive Preclinical Data Differentiating Mechanism of Action of PH94B from Risk-Ridden Benzodiazepines
- Nov 11 2020 Retrophin to Present at Upcoming Investor Conferences
- Nov 9 2020 VistaGen Therapeutics to Participate in the Guggenheim Healthcare Talks | Idea Forum | 2nd Annual Neuro/Immunology Day
- Nov 9 2020 BG Staffing, Inc. to Participate in the Virtual Southwest IDEAS Investor Conference